Title

Oral Versus Intramuscular Cobalamin Treatment In Megaloblastic Anemia: A Single-Center, Prospective, Randomized, Open-Label Study

Creator

Tiara Bianco, University of New EnglandFollow
John Wironen, University of New EnglandFollow

Faculty Advisor(s)

Dana L. Villmore

Files

Description

Research review poster of article:
Bolaman, Z., Kadikoylu, G., Yukselen, V., Yavasoglu, I., Barutca, S., & Senturk, T. (2003). Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study. Clinical therapeutics, 25(12), 3124–3134. doi:10.1016/s0149-2918(03)90096-8

UNE Physician Assistant students reviewed research whose purpose was to compare the treatments of PO versus IM cobalamin for patients with megaloblastic anemia due to a cobalamin deficiency in terms of cost and effectiveness.

Publication Date

12-2019

Disciplines

Medicine and Health Sciences

Related Materials

Original research article:
Bolaman, Z., Kadikoylu, G., Yukselen, V., Yavasoglu, I., Barutca, S., & Senturk, T. (2003). Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study. Clinical therapeutics, 25(12), 3124–3134. doi:10.1016/s0149-2918(03)90096-8

Preferred Citation

Bianco, Tiara and Wironen, John, "Oral Versus Intramuscular Cobalamin Treatment In Megaloblastic Anemia: A Single-Center, Prospective, Randomized, Open-Label Study" (2019). Physician Assistant Student Research Posters. 3.
https://dune.une.edu/pa_studpost/3